Finance

Lists
000220:KRX
Yuyu Pharma Inc
၃,၈၁၅.၀၀ ₩
+၁.၆၀%
(+၆၀.၀၀) 1D
အောက် ၁၉, GMT+၉ ၁၅:၃၀:၃၀  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000220...
Open
၃,၆၉၀ ₩
High
၃,၈၇၀ ₩
Low
၃,၆၉၀ ₩
Mkt. cap
ဋေ ၇.၀၉ ထ
Avg. vol.
၁.၇၉ သိန်း
Volume
၇.၁၈ သောင်း
Dividend
၃.၀၁%
Quarterly dividend
၂၉ ₩
Ex-dividend date
၂၀၂၄ ဒီ ၂၇
P/E ratio
၅.၇၀
52-wk high
၅,၁၀၀ ₩
52-wk low
၃,၃၂၀ ₩
EPS
၆၆၉ ₩
Shares outstanding
၁.၅၇ ကုဋေ
No. of employees
၂၄၃
Open
၃,၆၉၀ ₩
High
၃,၈၇၀ ₩
Low
၃,၆၉၀ ₩
Mkt. cap
ဋေ ၇.၀၉ ထ
Avg. vol.
၁.၇၉ သိန်း
Volume
၇.၁၈ သောင်း
Dividend
၃.၀၁%
Quarterly dividend
၂၉ ₩
Ex-dividend date
၂၀၂၄ ဒီ ၂၇
P/E ratio
၅.၇၀
52-wk high
၅,၁၀၀ ₩
52-wk low
၃,၃၂၀ ₩
EPS
၆၆၉ ₩
Shares outstanding
၁.၅၇ ကုဋေ
No. of employees
၂၄၃
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၇ မိနစ်
Why Is Recursion Pharmaceuticals (RXRX) Drawing Attention After AI Drug And Trial Milestones?
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၅ မိနစ်
Amazon.com (NASDAQ:AMZN) Stock Picked Up by Analysts at Yorkville Ives
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၄ နာရီ
Goldman Sachs is still betting on a nice year-end rally for the S&P 500
About Yuyu Pharma Inc
CEO-
Employees၂၄၃
Founded၁၉၄၁
Headquarters-
Sector-
Websiteyuyu.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၃.၇၈ ထ
ဋေ ၃.၄၃ ထ
ဋေ ၃.၅၅ ထ
ဋေ ၃.၆၇ ထ
Cost of goods sold
ဋေ ၂.၃၀ ထ
ဋေ ၂.၂၅ ထ
ဋေ ၂.၁၀ ထ
ဋေ ၂.၂၁ ထ
Cost of revenue
ဋေ ၂.၃၀ ထ
ဋေ ၂.၂၅ ထ
ဋေ ၂.၁၀ ထ
ဋေ ၂.၂၁ ထ
Research and development expenses
၉၁.၄၉ ကုဋေ
၁၁၅.၃၁ ဋေ
၇၀.၃၄ ကုဋေ
၇၈.၁၉ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈၇၁.၄၆ ဋေ
ဋေ ၁.၀၂ ထ
၈၉၄.၆၁ ဋေ
၉၃၂.၆၅ ဋေ
Operating expense
၉၈၀.၉၅ ဋေ
ဋေ ၁.၁၉ ထ
ဋေ ၁.၀၂ ထ
ဋေ ၁.၀၆ ထ
Total operating expenses
ဋေ ၃.၂၈ ထ
ဋေ ၃.၄၅ ထ
ဋေ ၃.၁၂ ထ
ဋေ ၃.၂၇ ထ
Operating income
၄၉၈.၅၅ ဋေ
-၁၂.၉၁ ကုဋေ
၄၃၀.၂၉ ဋေ
၄၀၀.၂၅ ဋေ
Other non operating income
၅.၆၇ ကုဋေ
-၁၁၃.၀၄ ဋေ
၈၆.၃၆ ကုဋေ
-၁၈.၄၄ ကုဋေ
EBT including unusual items
၄၈၂.၁၉ ဋေ
၂၀.၂၀ ကုဋေ
၃၉၇.၂၁ ဋေ
၄၁၂.၉၇ ဋေ
EBT excluding unusual items
၄၇၆.၇၇ ဋေ
-၁၁၀.၈၈ ဋေ
၄၉၉.၀၂ ဋေ
၃၆၇.၈၄ ဋေ
Income tax expense
၅၀.၄၃ ကုဋေ
-၁၀၀.၄၀ ဋေ
၆၂.၀၅ ကုဋေ
၅၇.၄၅ ကုဋေ
Effective tax rate
၁၀.၄၆%
-၄၉၆.၉၇%
၁၅.၆၂%
၁၃.၉၁%
Other operating expenses
၁.၈၃ ကုဋေ
၇.၆၂ ကုဋေ
၄.၀၉ ကုဋေ
၃.၆၉ ကုဋေ
Net income
၃၉၇.၆၆ ဋေ
၁၃၈.၅၂ ဋေ
၃၄၉.၁၃ ဋေ
၃၆၅.၀၈ ဋေ
Net profit margin
၁၀.၅၂%
၄.၀၃%
၉.၈၂%
၉.၉၅%
Earnings per share
-
-
-
-
Interest and investment income
၁၃.၆၁ ကုဋေ
၅၃.၀၀ ကုဋေ
၂၈.၆၄ ကုဋေ
၂၂.၆၈ ကုဋေ
Interest expense
-၅၄.၀၄ ကုဋေ
-၅၄.၇၁ ကုဋေ
-၄၇.၄၃ ကုဋေ
-၄၃.၆၄ ကုဋေ
Net interest expenses
-၄၀.၄၃ ကုဋေ
-၁.၇၁ ကုဋေ
-၁၈.၇၉ ကုဋေ
-၂၀.၉၇ ကုဋေ
Depreciation and amortization charges
၃၂.၁၀ ကုဋေ
၄၀.၃၃ ကုဋေ
၃၃.၄၉ ကုဋေ
၄၀.၉၃ ကုဋေ
EBITDA
၆၃၄.၃၆ ဋေ
၁၃၂.၉၃ ဋေ
၅၆၇.၈၉ ဋေ
၅၄၆.၂၅ ဋေ
Gain or loss from assets sale
-၁.၃၃ ကုဋေ
-
-၄.၉၉ သိန်း
-၃.၁၉ သန်း
AI content may include mistakes. Learn more
Google အက်ပ်များ